Researchers found no association between the use of DPP-4 inhibitors, GLP-1 receptor agonists, or SGLT2 inhibitors and the risk for fracture in patients with type 2 diabetes.
Patients with midlife type 2 diabetes have a significantly increased risk for cerebral infarction and occlusion of cerebral arteries later in life.
Compared with the first 3 years of denosumab treatment, a longer duration of denosumab therapy was associated with further decrease in nonvertebral fracture rate, which was sustained through 10 years of treatment.
Osteopenia was found in more than 25% of both men and women, suggesting that more osteoporosis screening and prevention programs are needed in middle-age individuals.
Researchers sent adults with type 1 diabetes a quantitative survey in order to better understand unmet needs and patient preferences.
Incidence rates of pediatric thyroid cancer have increased in the United States, likely attributable to enhanced diagnostic practices and an increase in thyroid cancer in the pediatric population.
Researchers used epidemiologic evidence to better understand the risk for osteoporosis and osteoarthritis in patients with cerebral palsy.
Compared with cisgender men, transgender women who receive gender-affirming hormone treatment are at significantly increased risk for invasive breast cancer.
For patients with inadequately controlled type 2 diabetes, self-managed titration of insulin glargine 300 U/mL is superior to physician-managed titration.
Cardiorespiratory fitness does not offset the links between adiposity and certain inflammatory biomarkers in older women who are physically active.
